Stocks and Investing Stocks and Investing
Fri, August 4, 2023

Joseph Stringer Reiterated (VIR) at Strong Buy and Held Target at $22 on, Aug 4th, 2023


Published on 2024-10-28 05:31:12 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Reiterated "Vir Biotechnology, Inc." (VIR) at Strong Buy and Held Target at $22 on, Aug 4th, 2023.

Joseph has made no other calls on VIR in the last 4 months.



There are 4 other peers that have a rating on VIR. Out of the 4 peers that are also analyzing VIR, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michelle Gilson of "Morgan Stanley" Maintained at Hold with Decreased Target to $15 on, Friday, July 21st, 2023


These are the ratings of the 3 analyists that currently disagree with Joseph


  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $41 on, Friday, July 21st, 2023
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $28 on, Friday, July 21st, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $100 on, Thursday, July 20th, 2023

Contributing Sources